Drug Discovery

Transcription factors act as biological switches that, when stuck in the 'on' position, trigger the rapid and unregulated cell division characteristic of malignant tumors. For decades, these pivotal components of cellular machinery have remained largely out of reach for modern pharmacology, leading

A massive collaborative effort between Parse Biosciences and Nomic Bio aims to solve the industry's most persistent bottleneck by generating a multimodal dataset of 100 million individual cells. Launched in late 2026, Project Cascade represents a fundamental shift in how the scientific community

A dual-sourcing strategy ensures that the pursuit of environmental milestones does not compromise the security of the supply chain for essential medical treatments. As global healthcare systems face unprecedented demand, the pharmaceutical industry is increasingly pressured to harmonize life-saving

Biological engineers have spent decades searching for a nanoscale Swiss Army knife that can simultaneously alert the immune system and deliver precision-guided payloads to malignant cells without the systemic toxicity typically associated with traditional chemotherapy. The M13 bacteriophage, a

Approximately 20 percent of all breast cancer diagnoses are classified as HER2-positive, a subtype historically associated with aggressive growth and poor clinical outcomes. The landscape of HER2-positive early breast cancer treatment has undergone a significant transformation with the European

Approximately eighty-three percent of the genes involved in immune function are influenced by genetic variants that often operate in a context-dependent manner. This revelation comes from a massive collaborative effort between the Garvan Institute of Medical Research and the University of New South